BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37879115)

  • 1. Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study.
    Pries-Heje MM; Hjulmand JG; Lenz IT; Hasselbalch RB; Povlsen JA; Ihlemann N; Køber N; Tofterup ML; Østergaard L; Dalsgaard M; Faurholt-Jepsen D; Wienberg M; Christiansen U; Bruun NE; Fosbøl E; Moser C; Iversen KK; Bundgaard H
    Eur Heart J; 2023 Dec; 44(48):5095-5106. PubMed ID: 37879115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis.
    Iversen K; Ihlemann N; Gill SU; Madsen T; Elming H; Jensen KT; Bruun NE; Høfsten DE; Fursted K; Christensen JJ; Schultz M; Klein CF; Fosbøll EL; Rosenvinge F; Schønheyder HC; Køber L; Torp-Pedersen C; Helweg-Larsen J; Tønder N; Moser C; Bundgaard H
    N Engl J Med; 2019 Jan; 380(5):415-424. PubMed ID: 30152252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated treatment of endocarditis-The POET II trial: Rationale and design of a randomized controlled trial.
    Østergaard L; Pries-Heje MM; Hasselbalch RB; Rasmussen M; Åkesson P; Horvath R; Povlsen J; Gill S; Bruun NE; Müllertz K; Tuxen CD; Ihlemann N; Helweg-Larsen J; Moser C; Fosbøl EL; Bundgaard H; Iversen K
    Am Heart J; 2020 Sep; 227():40-46. PubMed ID: 32673830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study.
    Østergaard L; Bruun NE; Voldstedlund M; Arpi M; Andersen CØ; Schønheyder HC; Lemming L; Rosenvinge F; Valeur N; Søgaard P; Andersen PS; Skov R; Chen M; Iversen K; Gill S; Lauridsen TK; Dahl A; Oestergaard LB; Povlsen JA; Moser C; Bundgaard H; Køber L; Fosbøl EL
    Eur Heart J; 2019 Oct; 40(39):3237-3244. PubMed ID: 31145782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Vegetation Size and Outcome in the Partial Oral Antibiotic Endocarditis Treatment Trial.
    Carter-Storch R; Pries-Heje MM; Povlsen JA; Christensen U; Gill SU; Hjulmand JG; Bruun NE; Elming H; Madsen T; Fuursted K; Schultz M; Christensen JJ; Rosenvinge F; Helweg-Larsen J; Fosbøl E; Køber L; Torp-Pedersen C; Tønder N; Moser C; Iversen K; Bundgaard H; Ihlemann N
    Am J Cardiol; 2024 Jul; 222():131-140. PubMed ID: 38703884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials.
    Lemaignen A; Bernard L; Tattevin P; Bru JP; Duval X; Hoen B; Brunet-Houdard S; Mainardi JL; Caille A;
    BMJ Open; 2020 Jul; 10(7):e033540. PubMed ID: 32665381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of persistent positive blood cultures and infective endocarditis: A cohort study among patients with suspected infective endocarditis.
    Teixeira Antunes A; Monney P; Tzimas G; Tozzi P; Kirsch M; Guery B; Papadimitriou-Olivgeris M
    Int J Infect Dis; 2024 Jun; 143():107022. PubMed ID: 38561042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
    Heldman AW; Hartert TV; Ray SC; Daoud EG; Kowalski TE; Pompili VJ; Sisson SD; Tidmore WC; vom Eigen KA; Goodman SN; Lietman PS; Petty BG; Flexner C
    Am J Med; 1996 Jul; 101(1):68-76. PubMed ID: 8686718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
    Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
    Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of bacteremia and infective endocarditis according to bacterial species of index endocarditis episode.
    Østergaard L; Voldstedlund M; Bruun NE; Bundgaard H; Iversen K; Pries-Heje MM; Hadji-Turdeghal K; Graversen PL; Moser C; Andersen CØ; Søgaard KK; Køber L; Fosbøl EL
    Infection; 2023 Dec; 51(6):1739-1747. PubMed ID: 37395924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
    Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM;
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review.
    Spellberg B; Chambers HF; Musher DM; Walsh TL; Bayer AS
    JAMA Intern Med; 2020 May; 180(5):769-777. PubMed ID: 32227127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trial (SATIE).
    Olmos C; Vilacosta I; López J; Sáez C; Anguita M; García-Granja PE; Sarriá C; Silva J; Álvarez-Álvarez B; Martínez-Monzonis MA; Castillo JC; Seijas J; López-Picado A; Peral V; Maroto L; San Román JA
    BMC Infect Dis; 2020 Jun; 20(1):417. PubMed ID: 32546269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study.
    Freling S; Wald-Dickler N; Banerjee J; Canamar CP; Tangpraphaphorn S; Bruce D; Davar K; Dominguez F; Norwitz D; Krishnamurthi G; Fung L; Guanzon A; Minejima E; Spellberg M; Spellberg C; Baden R; Holtom P; Spellberg B
    Clin Infect Dis; 2023 Sep; 77(5):672-679. PubMed ID: 36881940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles.
    Anguera I; Del Río A; Miró JM; Matínez-Lacasa X; Marco F; Gumá JR; Quaglio G; Claramonte X; Moreno A; Mestres CA; Mauri E; Azqueta M; Benito N; García-de la María C; Almela M; Jiménez-Expósito MJ; Sued O; De Lazzari E; Gatell JM;
    Heart; 2005 Feb; 91(2):e10. PubMed ID: 15657200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Changes, Patient Characteristics, and Mortality, According to Microbiological Cause of Infective Endocarditis: A Nationwide Study.
    Østergaard L; Voldstedlund M; Bruun NE; Bundgaard H; Iversen K; Køber N; Christensen JJ; Rosenvinge FS; Jarløv JO; Moser C; Andersen CØ; Coia J; Marmolin ES; Søgaard KK; Lemming L; Køber L; Fosbøl EL
    J Am Heart Assoc; 2022 Aug; 11(16):e025801. PubMed ID: 35946455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study.
    Shrestha NK; Shah SY; Wang H; Hussain ST; Pettersson GB; Nowacki AS; Gordon SM
    Ann Thorac Surg; 2016 Jun; 101(6):2243-50. PubMed ID: 26872729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of infective endocarditis with focus on non-device related right-sided infective endocarditis: A retrospective register-based study in the region of Southern Denmark.
    Lassen H; Nielsen SL; Gill SUA; Johansen IS
    Int J Infect Dis; 2020 Jun; 95():224-230. PubMed ID: 32289560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Analysis of Intravenous vs Oral Antibiotic Step-Down Therapy for the Treatment of Uncomplicated Streptococcal Bloodstream Infections.
    Ramos-Otero GP; Sarangarm P; Walraven C
    J Clin Pharmacol; 2022 Nov; 62(11):1372-1378. PubMed ID: 35661173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci.
    Hidalgo-Tenorio C; Sadyrbaeva-Dolgova S; Enríquez-Gómez A; Muñoz P; Plata-Ciezar A; Miró JM; Alarcón A; Martínez-Marcos FJ; Loeches B; Escrihuela-Vidal F; Vinuesa D; Herrero C; Boix-Palop L; Del Mar Arenas M; Vázquez EG; de Las Revillas FA; Pasquau J;
    Int J Antimicrob Agents; 2023 Sep; 62(3):106918. PubMed ID: 37442488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.